Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to work with NHS England and with the devolved administrations to ensure that socioeconomic benefits from immunisation, including those relating to productivity, can be fully realised in the UK.

The Department continues to work across the health system, with the devolved administrations, to deliver robust, cost-effective programmes which benefit public health. The Joint Committee for Vaccination and Immunisation (JCVI) advises on the approach to immunisation, and also evaluates opportunities to deliver robust, cost-effective programmes that protect public health. Investments in vaccines and other health interventions are assessed for cost effectiveness within a broader framework that allows one intervention to be assessed fairly alongside another.

While the JCVI does not consider productivity and economic outcomes, the Department can still opt to consider the productivity and economic impacts of immunisation, where this is judged to be an important additional consideration, in line with His Majesty's Treasury’s Green Book guidance.